Status:
UNKNOWN
Evaluation of a Single Center Expansion of Continuous Glucose Monitor Access in Patients With Type 2 Diabetes
Lead Sponsor:
Chieh Chen
Collaborating Sponsors:
St. John Fisher College
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this pilot study is to hopefully generate interest that will lead to more robust trials evaluating FreeStyle Libre 2 sensors in patients with type 2 diabetes on any diabetes regimen. Ho...
Detailed Description
This will be a prospective, single-center, pre-post pilot study where enrolled participants will be given free FreeStyle Libre 2 sensors for 3 months and will be followed by pharmacists in the Upstate...
Eligibility Criteria
Inclusion
- Diagnosis of Type 2 Diabetes with
- Hemoglobin A1c above goal 6.5%-8% based on participant specific factors defined in the ADA guidelines (e.g. comorbidities and age) OR
- Identified glycemic excursions, including hypoglycemia based on documented blood glucose readings of \< 70 mg/dL via point-of-care glucose testing, lab testing or self-monitoring or reported signs and symptoms of hypoglycemia documented in the medical record
- Referred and actively followed by pharmacy for at least 3 months prior to study enrollment
- Have at least one encounter with pharmacist within the last 3 months
- Have at least one A1c documented while under pharmacist care
- On at least one anti-diabetic medication
- Demonstrates willingness (at the discretion of the investigators) to scan the CGM several times a day
- Demonstrates willingness (at the discretion of the investigators) to attend regular office visits or phone calls
Exclusion
- Currently pregnant or actively trying to conceive
- Receiving dialysis
- Currently followed by the endocrinology clinic for diabetes
- Current or past CGM use in the last 6 months prior to study enrollment
- Participant meets criteria for insurance coverage of CGM
- Known allergy to medical adhesive
- Wearing any implanted medical device
Key Trial Info
Start Date :
January 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05200390
Start Date
January 24 2022
End Date
February 1 2023
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Upstate Health Care Center
Syracuse, New York, United States, 13202